SP Scientific Launches Versatile Accessory for Bulk and Flask Freeze Drying
SP Scientific has announced the Horizontal Drum Manifold — a new accessory to maximize the performance of its BenchTop Pro freeze dryer while adding bulk and flask drying capabilities for aqueous application.
Designed for use with 3-, 8- and 9-L BenchTop Pro units the new manifold provides a highly economic solution to further increase the versatility of the popular tray dryer either purchased with a new system or easily assembled on an existing unit in the field with no additional hardware required.
The Horizontal Drum Manifold comes standard with two adjustable unheated trays that provide ample room for bulk samples such as plants, leaf punches, seeds, well plates,or samples in serum bottles or vials of widely varying sizes. If needed, an optional support tray is available to collect condensate and a third shelf is available for applications involving freeze drying samples in 5 mL and 10 mL flasks. All trays are easily removed for cleaning.
To optimize productivity the Horizontal Drum Manifold includes eight QuickSeal valves that enable parallel connection of flasks and other freeze drying glassware. Durably constructed with a 'clear view' acrylic door and drum the Horizontal Drum Manifold enables easy visual monitoring of the product drying process.
BenchTop Pro freeze dryers have been designed to meet the needs of the most demanding research laboratories. Each system can be configured to meet your present and future needs. Condenser refrigeration packages of -55 °C, -75 °C, -85 °C and -105 °C can meet the demands of both aqueous and aqueous-solvent based formulations.
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.